🔼Аналитик Craig-Hallum Александр Новак повысил целевую цену акций Tandem Diabetes Care, Inc. (TNDM) до $140 с $102 и сохраняет рейтинг «Покупать» по итогам квартальных результатов компании

Новак говорит, что квартал был «впечатляющим», с сочетанием исполнения, положительных результатов UnitedHealth (UNH) и успеха Control-IQ, что вселяет в него уверенность.

#tndm

🔥Понижений рейтингов от аналитиков инвестдомов

@usstocksnews | YouTube | VK Видео | Чат

#AGCO: Baird Downgrades to Neutral from Outperform - PT $100 (from $116)

#CNH: Baird Downgrades to Neutral from Outperform - PT $15 (from $16)

#DE: Baird Downgrades to Neutral from Outperform - PT $501

#DG: Deutsche Bank Downgrades to Hold from Buy - PT $80 (from $90)

#DV: Cannonball Research Downgrades to Neutral from Buy - PT $14

#FOX: Arete Downgrades to Neutral from Buy - PT $66

#FTAI: Stifel Downgrades to Hold from Buy - PT $123 (from $100)

#KC: Nomura Downgrades to Neutral from Buy - PT $18.10 (from $6.70)

#KRP: Raymond James Downgrades to Market Perform from Strong Buy

#LUV: JPMorgan Downgrades to Underweight from Neutral - PT $25

#SRE: Jefferies Downgrades to Hold from Buy - PT $77 (from $96)

#TNDM: Bernstein Downgrades to Market Perform from Outperform - PT $25 (from $35)

#TNDM: Wells Fargo Downgrades to Equal Weight from Overweight - PT $22 (from $38)

#ZLAB: BofA Securities Downgrades to Neutral from Buy - PT $36.10 (from $29)

#рейтинги #прогнозы

Для обсуждения переходи в чат t.iss.one/USstocksnews_chat